Pharma R&D Today

Ideas and Insight supporting all stages of Drug Discovery & Development

Select category
Search this blog

Government Shutdown Could Have Lasting Impact on Scientific Research

Posted on January 26th, 2019 by in Pharma R&D

The U.S. government shutdown dragged on past the one-month mark, creating financial panic for many government workers and resulting in a ripple of negative affects across the country. Continue reading “Government Shutdown Could Have Lasting Impact on Scientific Research” »

Government Shutdown Means New Drugs May Have to Wait – But Safety Monitoring Will Continue

Posted on January 17th, 2019 by in Pharma R&D

The partial shutdown of the U.S. government, which began just before the Christmas holiday, has been especially terrible for hundreds of thousands of federal employees who are either furloughed or working without pay. Continue reading “Government Shutdown Means New Drugs May Have to Wait – But Safety Monitoring Will Continue” »

FDA Announces Plans to Improve Approvals Process for Medical Devices

Posted on January 15th, 2019 by in Pharma R&D

In the pharmaceutical industry, safety protocols are rigorous. Clinical trials, a lengthy and intense part of the drug development process, are deemed absolutely crucial to ensuring the safety and efficacy of new drugs and therapies. There are also many regulations designed to make certain that high standards are maintained during the various trial phases.

Continue reading “FDA Announces Plans to Improve Approvals Process for Medical Devices” »